ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GRAL vs JNJ // FREE CASH FLOW YIELD

GRAIL Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: GRAL 3 — JNJ 8
▲ FREE CASH FLOW YIELD LEADER: JNJ
fcf-yield
-4.23%
fcf-yield
2.97%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRAL VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GRAL JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 67.90% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -18.00% 25.50% -43.50 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -4.23% 2.97% -7.20 JNJ /fcf-yield <GO>
Operating Margin -60.00% 34.70% -94.70 JNJ /operating-margins <GO>
Net Profit Margin -60.00% 28.50% -88.50 JNJ /net-margins <GO>
Revenue Growth (YoY) 17.20% 6.00% +11.20 GRAL /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 7.26 5.59 +1.67 GRAL /balance-sheet <GO>
Piotroski F-Score Quality 6/9 8/9 -2.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.0 59.1 -5.10 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.00 1.08 -0.08 JNJ /macro-sensitivity <GO>
Forward P/E Multiple 22.0x 23.0x -1.00 GRAL /forward-pe <GO>
Enterprise Scale & Market Cap $6.41B $657.68B -$651.27B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GRAL REV JNJ REV GRAL GROSS % JNJ GROSS % GRAL FCF JNJ FCF
FY 2025 $147.2M $94.19B — 67.9% -$299.9M $19.70B
FY 2024 $125.6M $88.82B — 69.1% -$582.4M $19.84B
FY 2023 $93.1M $85.16B — — -$600.0M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRAL // BETA 1.00
JNJ // BETA 1.08